126 related articles for article (PubMed ID: 34997618)
1. Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology.
Orzińska A; Kluska A; Balabas A; Piatkowska M; Kulecka M; Ostrowski J; Mikula M; Dębska M; Uhrynowska M; Guz K
Transfusion; 2022 Feb; 62(2):458-468. PubMed ID: 34997618
[TBL] [Abstract][Full Text] [Related]
2. Prediction of fetal blood group and platelet antigens from maternal plasma using next-generation sequencing.
Orzińska A; Guz K; Mikula M; Kluska A; Balabas A; Ostrowski J; Uhrynowska M; Kopeć I; Dębska M; Luterek K; Brojer E
Transfusion; 2019 Mar; 59(3):1102-1107. PubMed ID: 30620409
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive Prenatal Diagnosis of Feto-Maternal Platelet Incompatibility by Cold High Resolution Melting Analysis.
Ferro M; Macher HC; Noguerol P; Jimenez-Arriscado P; Molinero P; Guerrero JM; Rubio A
Adv Exp Med Biol; 2016; 924():67-70. PubMed ID: 27753021
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive prenatal HPA-1 typing in HPA-1a negative pregnancies selected in the Polish PREVFNAIT screening program.
Orzińska A; Guz K; Uhrynowska M; Dębska M; Mikula M; Ostrowski J; Ahlen MT; Husebekk A; Brojer E
Transfusion; 2018 Nov; 58(11):2705-2711. PubMed ID: 30260485
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.
Wienzek-Lischka S; Krautwurst A; Fröhner V; Hackstein H; Gattenlöhner S; Bräuninger A; Axt-Fliedner R; Degenhardt J; Deisting C; Santoso S; Sachs UJ; Bein G
Transfusion; 2015 Jun; 55(6 Pt 2):1538-44. PubMed ID: 25873286
[TBL] [Abstract][Full Text] [Related]
6. Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia - current status.
Avent ND
Expert Rev Hematol; 2014 Dec; 7(6):741-5. PubMed ID: 25374152
[TBL] [Abstract][Full Text] [Related]
7. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
8. A new efficient tool for non-invasive diagnosis of fetomaternal platelet antigen incompatibility.
Ouzegdouh Mammasse Y; Chenet C; Drubay D; Martageix C; Cartron JP; Vainchenker W; Petermann R
Br J Haematol; 2020 Sep; 190(5):787-798. PubMed ID: 32266719
[TBL] [Abstract][Full Text] [Related]
9. Maternal incompatibilities with fetal human platelet alloantigens -1a, -1b and -15 are the main causes of neonatal alloimmune thrombocytopenia in Russia.
Khaspekova SG; Golovkina LL; Donush EK; Golubeva NV; Shustova ON; Mazurov AV
Ter Arkh; 2018 Aug; 90(7):65-69. PubMed ID: 30701924
[TBL] [Abstract][Full Text] [Related]
10. A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.
Orzińska A; Guz K; Mikula M; Kulecka M; Kluska A; Balabas A; Pelc-Kłopotowska M; Ostrowski J; Brojer E
Blood Transfus; 2018 May; 16(3):285-292. PubMed ID: 28287381
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility.
Ferro M; Macher HC; Fornés G; Martín-Sánchez J; Jimenez-Arriscado P; Molinero P; Pérez-Simón JA; Guerrero JM; Rubio A
Transfusion; 2018 Oct; 58(10):2272-2279. PubMed ID: 30222855
[TBL] [Abstract][Full Text] [Related]
12. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.
Winkelhorst D; de Vos TW; Kamphuis MM; Porcelijn L; Lopriore E; Oepkes D; van der Schoot CE; de Haas M
BMJ Open; 2020 Jul; 10(7):e034071. PubMed ID: 32690731
[TBL] [Abstract][Full Text] [Related]
13. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
[TBL] [Abstract][Full Text] [Related]
15. Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fy
Alford B; Landry BP; Hou S; Bower X; Bueno AM; Chen D; Husic B; Cantonwine DE; McElrath TF; Carozza JA; Wynn J; Hoskovec J; Gray KJ
Sci Rep; 2023 Aug; 13(1):12786. PubMed ID: 37550335
[TBL] [Abstract][Full Text] [Related]
16. Safe fetal platelet genotyping: new developments.
Le Toriellec E; Chenet C; Kaplan C
Transfusion; 2013 Aug; 53(8):1755-62. PubMed ID: 23146000
[TBL] [Abstract][Full Text] [Related]
17. Antibody formation in pregnant women with maternal-neonatal human platelet antigen mismatch from a hospital in northern Taiwan.
Yang WH; Cheng CS; Chang JB; Liu KT; Chang JL
Kaohsiung J Med Sci; 2014 Jan; 30(1):25-8. PubMed ID: 24388055
[TBL] [Abstract][Full Text] [Related]
18. Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.
Weng YJ; Husebekk A; Skogen B; Kjaer M; Lin LT; Burnouf T
PLoS One; 2016; 11(9):e0162973. PubMed ID: 27627660
[TBL] [Abstract][Full Text] [Related]
19. HPA-5 typing discrepancy reveals an Ile503Leu substitution in platelet GPIa (α2 integrin).
Bertrand G; Jallu V; Beranger T; Bianchi F; Casale C; Dufour V; Chenet C; Quesne J; Martageix C; Kaplan C
Vox Sang; 2013 Jul; 105(1):73-6. PubMed ID: 23368983
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in non-invasive fetal HPA-1a typing.
Nogués N
Transfus Apher Sci; 2020 Feb; 59(1):102708. PubMed ID: 31953107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
